Management of genital warts

Area of Science:

• Dermatology
• Infectious Diseases
• Primary Care Medicine

Background:

• Genital warts, resulting from human papillomavirus (HPV) infection, are frequently managed in primary care settings.
• Limited evidence has historically guided treatment selection, but recent updates to treatment guidelines are notable.
• Routine diagnostic measures like biopsy or viral typing are generally not required for genital warts.

Purpose of the Study:

• To review current evidence and updated guidelines for the management of genital warts.
• To outline treatment goals, focusing on visible wart clearance and potential reduction in infectivity.
• To inform treatment choices based on lesion characteristics, patient factors, and available therapies.

Main Methods:

• Review of current medical literature and treatment guidelines for human papillomavirus-induced genital warts.
• Analysis of factors influencing treatment selection, including lesion characteristics and patient preferences.
• Evaluation of the efficacy, convenience, and cost-effectiveness of various treatment modalities.

Main Results:

• The primary goal of treatment is the clearance of visible genital warts; treatment may reduce infectivity but not cancer incidence.
• Patient-applied therapies, such as imiquimod cream and podofilox, are increasingly recommended.
• Podofilox, imiquimod, surgical excision, and cryotherapy are identified as convenient and effective treatment options.
• Fluorouracil and interferon are no longer recommended for routine management.
• The approximate cost for a successful treatment course ranges from $200 to $300 across multiple effective therapies.

Conclusions:

• Treatment choice for genital warts depends on lesion specifics, patient preferences, and cost-effectiveness.
• Patient-applied therapies and established methods like cryotherapy and surgical excision are preferred.
• Updated guidelines emphasize practical and effective approaches to managing common HPV infections.